Helicobacter pylori, a gramnegative and microaerophilic organism, is transmitted from person-to-person through the feco-oral route and colonizes the stomach. The organism persists in the healthy host in equilibrium, which is disturbed at times, leading to formation of peptic ulcer and gastric cancer. Presence of H. pylori in the biliary tree of a small proportion of individuals has led to the conjecture that it is a potential cause of gallbladder disease. The exact pathway of how the organism reaches the gallbladder is unclear. It could reach the gallbladder directly from the stomach or through the portal blood circulation. In contrast to the stomach, colonization of the gallbladder is unlikely due to the alkaline pH of bile, H. pylori being known to thrive at the low pH of gastric juice.There are several tests to confirm presence of H. pylori in the stomach. These include rapid urease test, and demonstration of the bacterium on histology and culture of gastric biopsy, and positive urea breath ( 13 C or 14 C) test. Molecular tests identify the genes of H. pylori in the tissue. Immunological evidence of H. pylori infection is provided by presence of H. pylori-specific IgG and IgM antibodies in the blood. Similar tests can be used to demonstrate H. pylori in gallbladder and bile.Demonstration of H. pylori in gallbladder has been attempted directly by culture of gallbladder, bile or gallbladder mucosal scrappings or demonstration of the bacillus on histology of gallbladder. Indirect evidence of H. pylori in gallbladder by demonstration of DNA of different components of bacillus is found in 7 % to 61.5 % tissue examined [2][3][4][5][6][7][8][9][10].Evidence of immunological response to Helicobacter is often positive in patients with gallbladder disease. Antibodies to Helicobacter have been reported in 18 % to 80 % of patients with gallstone disease [2,[11][12][13], 32 % to 38.8 % of cancer gallbladder [2, 11] and 13.1 % to 47.5 % of controls [11,13]. However, serology is not specific for Helicobacter infection of the gallbladder. It is a systemic effect of Helicobacter infection anywhere in the body.In this issue of the Journal, Bansal et al.[12] demonstrate the presence of H. pylori DNA in 32.6 % of 49 gallbladders surgically removed for benign biliary disease. None of these gallbladders showed H. pylori organisms on histology, even when special stains were used. DNA detection by PCR is very sensitive. Helicobacter genus (total 32 species) in general and H. pylori specifically are detected by an array of PCR tests using 26KDA, HSP60, Flagellin gene and other primers with varying sensitivities. The accuracy of the 26KDa primer is 9.3 % compared to that of 11.6 % using the Ure A gene on the same samples. Mishra and others [2] recently reported that 42.5 % of gallbladder carcinoma tissues were positive for the HSP60 gene. Bansal et al. [12] based the PCR on the UreA gene of H. pylori. However, it has been shown that this gene shares homology